164 related articles for article (PubMed ID: 29570846)
1. Neuroprotective Effects of Creatine in the CMVMJD135 Mouse Model of Spinocerebellar Ataxia Type 3.
Duarte-Silva S; Neves-Carvalho A; Soares-Cunha C; Silva JM; Teixeira-Castro A; Vieira R; Silva-Fernandes A; Maciel P
Mov Disord; 2018 May; 33(5):815-826. PubMed ID: 29570846
[TBL] [Abstract][Full Text] [Related]
2. In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
Schmidt J; Schmidt T; Golla M; Lehmann L; Weber JJ; Hübener-Schmid J; Riess O
J Neurochem; 2016 Jul; 138(1):150-62. PubMed ID: 26990650
[TBL] [Abstract][Full Text] [Related]
3. Preclinical Evidence Supporting Early Initiation of Citalopram Treatment in Machado-Joseph Disease.
Esteves S; Oliveira S; Duarte-Silva S; Cunha-Garcia D; Teixeira-Castro A; Maciel P
Mol Neurobiol; 2019 May; 56(5):3626-3637. PubMed ID: 30173407
[TBL] [Abstract][Full Text] [Related]
4. Far-infrared Radiation Improves Motor Dysfunction and Neuropathology in Spinocerebellar Ataxia Type 3 Mice.
Liu SW; Chang JC; Chuang SF; Liu KH; Cheng WL; Chang HJ; Chang HS; Lin TT; Hsieh CL; Lin WY; Hsieh M; Kuo SJ; Liu CS
Cerebellum; 2019 Feb; 18(1):22-32. PubMed ID: 29725949
[TBL] [Abstract][Full Text] [Related]
5. Beclin 1 mitigates motor and neuropathological deficits in genetic mouse models of Machado-Joseph disease.
Nascimento-Ferreira I; Nóbrega C; Vasconcelos-Ferreira A; Onofre I; Albuquerque D; Aveleira C; Hirai H; Déglon N; Pereira de Almeida L
Brain; 2013 Jul; 136(Pt 7):2173-88. PubMed ID: 23801739
[TBL] [Abstract][Full Text] [Related]
6. Calpain Inhibition Is Protective in Machado-Joseph Disease Zebrafish Due to Induction of Autophagy.
Watchon M; Yuan KC; Mackovski N; Svahn AJ; Cole NJ; Goldsbury C; Rinkwitz S; Becker TS; Nicholson GA; Laird AS
J Neurosci; 2017 Aug; 37(32):7782-7794. PubMed ID: 28687604
[TBL] [Abstract][Full Text] [Related]
7. Combined therapy with m-TOR-dependent and -independent autophagy inducers causes neurotoxicity in a mouse model of Machado-Joseph disease.
Duarte-Silva S; Silva-Fernandes A; Neves-Carvalho A; Soares-Cunha C; Teixeira-Castro A; Maciel P
Neuroscience; 2016 Jan; 313():162-73. PubMed ID: 26601773
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional profiling and biomarker identification reveal tissue specific effects of expanded ataxin-3 in a spinocerebellar ataxia type 3 mouse model.
Toonen LJA; Overzier M; Evers MM; Leon LG; van der Zeeuw SAJ; Mei H; Kielbasa SM; Goeman JJ; Hettne KM; Magnusson OT; Poirel M; Seyer A; 't Hoen PAC; van Roon-Mom WMC
Mol Neurodegener; 2018 Jun; 13(1):31. PubMed ID: 29929540
[TBL] [Abstract][Full Text] [Related]
9. Ibuprofen enhances synaptic function and neural progenitors proliferation markers and improves neuropathology and motor coordination in Machado-Joseph disease models.
Mendonça LS; Nóbrega C; Tavino S; Brinkhaus M; Matos C; Tomé S; Moreira R; Henriques D; Kaspar BK; Pereira de Almeida L
Hum Mol Genet; 2019 Nov; 28(22):3691-3703. PubMed ID: 31127937
[TBL] [Abstract][Full Text] [Related]
10. Microglial Depletion Has No Impact on Disease Progression in a Mouse Model of Machado-Joseph Disease.
Campos AB; Duarte-Silva S; Fernandes B; Coimbra B; Campos J; Monteiro-Fernandes D; Teixeira-Castro A; Ambrósio AF; Maciel P
Cells; 2022 Jun; 11(13):. PubMed ID: 35805106
[TBL] [Abstract][Full Text] [Related]
11. RNA interference mitigates motor and neuropathological deficits in a cerebellar mouse model of Machado-Joseph disease.
Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Déglon N; de Almeida LP
PLoS One; 2014; 9(8):e100086. PubMed ID: 25144231
[TBL] [Abstract][Full Text] [Related]
12. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3.
Menzies FM; Huebener J; Renna M; Bonin M; Riess O; Rubinsztein DC
Brain; 2010 Jan; 133(Pt 1):93-104. PubMed ID: 20007218
[TBL] [Abstract][Full Text] [Related]
13. Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype.
Kaemmerer WF; Rodrigues CM; Steer CJ; Low WC
Neuroscience; 2001; 103(3):713-24. PubMed ID: 11274790
[TBL] [Abstract][Full Text] [Related]
14. Genetic Ablation of Inositol 1,4,5-Trisphosphate Receptor Type 2 (IP
Cunha-Garcia D; Monteiro-Fernandes D; Correia JS; Neves-Carvalho A; Vilaça-Ferreira AC; Guerra-Gomes S; Viana JF; Oliveira JF; Teixeira-Castro A; Maciel P; Duarte-Silva S
Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37445783
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of mutant ataxin-3 in mouse cerebellum induces ataxia and cerebellar neuropathology.
Nóbrega C; Nascimento-Ferreira I; Onofre I; Albuquerque D; Conceição M; Déglon N; de Almeida LP
Cerebellum; 2013 Aug; 12(4):441-55. PubMed ID: 23242710
[TBL] [Abstract][Full Text] [Related]
16. RNA Interference Therapy for Machado-Joseph Disease: Long-Term Safety Profile of Lentiviral Vectors Encoding Short Hairpin RNAs Targeting Mutant Ataxin-3.
Nóbrega C; Codêsso JM; Mendonça L; Pereira de Almeida L
Hum Gene Ther; 2019 Jul; 30(7):841-854. PubMed ID: 30760052
[TBL] [Abstract][Full Text] [Related]
17. Trehalose alleviates the phenotype of Machado-Joseph disease mouse models.
Santana MM; Paixão S; Cunha-Santos J; Silva TP; Trevino-Garcia A; Gaspar LS; Nóbrega C; Nobre RJ; Cavadas C; Greif H; Pereira de Almeida L
J Transl Med; 2020 Apr; 18(1):161. PubMed ID: 32272938
[TBL] [Abstract][Full Text] [Related]
18. A new humanized ataxin-3 knock-in mouse model combines the genetic features, pathogenesis of neurons and glia and late disease onset of SCA3/MJD.
Switonski PM; Szlachcic WJ; Krzyzosiak WJ; Figiel M
Neurobiol Dis; 2015 Jan; 73():174-88. PubMed ID: 25301414
[TBL] [Abstract][Full Text] [Related]
19. T1-11 and JMF1907 ameliorate polyglutamine-expanded ataxin-3-induced neurodegeneration, transcriptional dysregulation and ataxic symptom in the SCA3 transgenic mouse.
Chou AH; Chen YL; Chiu CC; Yuan SJ; Weng YH; Yeh TH; Lin YL; Fang JM; Wang HL
Neuropharmacology; 2015 Dec; 99():308-17. PubMed ID: 26254860
[TBL] [Abstract][Full Text] [Related]
20. n-Butylidenephthalide exhibits protection against neurotoxicity through regulation of tryptophan 2, 3 dioxygenase in spinocerebellar ataxia type 3.
Rajamani K; Liu JW; Wu CH; Chiang IT; You DH; Lin SY; Hsieh DK; Lin SZ; Harn HJ; Chiou TW
Neuropharmacology; 2017 May; 117():434-446. PubMed ID: 28223212
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
